Skip to content

Nanoscope Therapeutics Inc.

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    Nanoscope Therapeutics appoints Troy Short as Senior Vice President, Manufacturing and Supply Chain

    Nanoscope Therapeutics announced on October 14, 2026 the appointment of Troy Short as Senior Vice President, Manufacturing and Supply Chain. In the role, Short will lead Nanoscope's GMP manufacturing, commercial supply, and global distribution strategy as the company advances MOGENRY (sonpiretigene isteparvovec; MCO-010) through regulatory review toward potential approval and launch.